[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2018900114A0 - 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents - Google Patents

5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents

Info

Publication number
AU2018900114A0
AU2018900114A0 AU2018900114A AU2018900114A AU2018900114A0 AU 2018900114 A0 AU2018900114 A0 AU 2018900114A0 AU 2018900114 A AU2018900114 A AU 2018900114A AU 2018900114 A AU2018900114 A AU 2018900114A AU 2018900114 A0 AU2018900114 A0 AU 2018900114A0
Authority
AU
Australia
Prior art keywords
thiazol
pyrimidin
therapeutic agents
urea derivatives
urea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018900114A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South Australia
Original Assignee
University of South Australia
Filing date
Publication date
Application filed by University of South Australia filed Critical University of South Australia
Publication of AU2018900114A0 publication Critical patent/AU2018900114A0/en
Priority to US16/961,986 priority Critical patent/US11325900B2/en
Priority to PCT/AU2019/000005 priority patent/WO2019136514A1/en
Priority to AU2019207517A priority patent/AU2019207517A1/en
Priority to CA3087805A priority patent/CA3087805A1/en
Priority to CN201980012403.9A priority patent/CN111757881B/en
Priority to JP2020538854A priority patent/JP7406808B2/en
Priority to EP19738966.1A priority patent/EP3740484B1/en
Priority to US17/724,629 priority patent/US20230092876A1/en
Abandoned legal-status Critical Current

Links

AU2018900114A 2018-01-15 2018-01-15 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents Abandoned AU2018900114A0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US16/961,986 US11325900B2 (en) 2018-01-15 2019-01-14 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents
PCT/AU2019/000005 WO2019136514A1 (en) 2018-01-15 2019-01-14 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents
AU2019207517A AU2019207517A1 (en) 2018-01-15 2019-01-14 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents
CA3087805A CA3087805A1 (en) 2018-01-15 2019-01-14 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents
CN201980012403.9A CN111757881B (en) 2018-01-15 2019-01-14 5- (Pyrimidin-4-yl) thiazol-2-yl urea derivatives as therapeutic agents
JP2020538854A JP7406808B2 (en) 2018-01-15 2019-01-14 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents
EP19738966.1A EP3740484B1 (en) 2018-01-15 2019-01-14 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents
US17/724,629 US20230092876A1 (en) 2018-01-15 2022-04-20 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents

Publications (1)

Publication Number Publication Date
AU2018900114A0 true AU2018900114A0 (en) 2018-01-25

Family

ID=

Similar Documents

Publication Publication Date Title
EP3889153A4 (en) Pyrimidine and five-membered nitrogen heterocycle derivative, preparation method therefor, and medical uses thereof
HK1259623A1 (en) Pyrazolo[1,5a]pyrimidine derivatives as irak4 modulators
RS65437B1 (en) (R) AND (S) ENANTIOMERS N-(5-(3-HYDROXYPYRROLIDIN-1-YL)-2-MORPHOLINOOXAZOLO[4,5-B]PYRIDIN-6-YL)-2-(2-METHYLPYRIDIN-4-YL) )OXAZOLE-CARBOXAMIDE AS IRAQ4 INHIBITORS FOR THE TREATMENT OF CANCER
EP3573583A4 (en) Active hand orthosis
EP3454896A4 (en) Heterocyclic derivatives for the thratment of rsv
EP3735463A4 (en) Cytotoxicity-inducing therapeutic agent
EP3492468A4 (en) Heterocyclic compound as jak inhibitor, and salts and therapeutic use thereof
EP3781576A4 (en) Boronic acid derivatives and therapeutic uses thereof
ZA202106024B (en) Heterocyclic derivatives
EP3888652A4 (en) Heterocyclic compound
EP3709998B8 (en) N-[5-(imidazo[1,2-a]pyrimidin-2-yl)phenyl]-benzamide and -benzeneacetamide derivatives as tnf stimulators for the treatment of e.g. infectious diseases and cancer
EP3901138A4 (en) Compound for use in retinal diseases
EP3952877A4 (en) Heterocyclic compounds and uses thereof
EP3807282A4 (en) Heterocyclic derivatives and use thereof
EP3807254A4 (en) Heterocyclic compounds useful in the treatment of disease
EP3740484A4 (en) 5- (PYRIMIDIN-4-YL) THIAZOL-2-YL UREA DERIVATIVES AS THERAPEUTIC AGENTS
EP3831811A4 (en) Heterocyclic compound
EP3618837A4 (en) Multitargeted nucleoside derivatives
AU2018900114A0 (en) 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents
EP3858838A4 (en) Heterocyclic compound
EP3579825A4 (en) Sulphamoylaryl derivatives and use thereof as medicaments for the treatment of liver fibrosis
HK40040026A (en) Heterocyclic compounds useful in the treatment of disease
HK40046931B (en) Therapeutic heterocyclic compounds
HK40052050A (en) Therapeutic heterocyclic compounds
HK40052049A (en) Therapeutic heterocyclic compounds